Hyperargininemia: clinical course and treatment with sodium benzoate and phenylacetic acid.
In a patient with hyperargininemia, oral administration of sodium benzoate or phenylacetic acid together with an essential amino acid mixture was used to prevent hyperammonemia and to decrease plasma and CSF concentrations of arginine. Sodium benzoate reduced the plasma ammonia levels, which was confirmed by the increase of urinary excretion of hippuric acid. Phenylacetic acid also controlled hyperammonemia, and EEG findings also improved. By these treatments, plasma and CSF concentrations of arginine showed a slight decrease, but were far above the normal range. There was no clinical improvement, and spasticity of the lower and upper extremities was progressive with mental deterioration.
D000592:Amino Acid Metabolism, Inborn Errors / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D000596:Amino Acids / Q000008:administration & dosage*; D000641:Ammonia / Q000097:blood; D001120:Arginine / Q000097:blood* / Q000134:cerebrospinal fluid; D001565:Benzoates / Q000008:administration & dosage*; D019817:Benzoic Acid; D002675:Child, Preschool; D004044:Dietary Proteins / Q000008:administration & dosage; D006801:Humans; D008297:Male; D010648:Phenylacetates / Q000008:administration & dosage*
D000596:Amino Acids; D001565:Benzoates; D004044:Dietary Proteins; D010648:Phenylacetates; D000641:Ammonia; D019817:Benzoic Acid; D001120:Arginine; C025136:phenylacetic acid